Osteoclasts activation by bacterial endotoxins during periodontal diseases;Activation de l'ostéoclasie par les endotoxines bactériennes au cours des maladies parodontales

Medecine/Sciences

Volumn 22, Issue 6-7, 2006, Pages 614-618

  Doucet, Philippe ^a   Lowenstein, Morgan ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ALVEOLAR BONE; BONE DESTRUCTION; GRAM NEGATIVE BACTERIUM; HUMAN; INFLAMMATION; OSTEOBLAST; OSTEOCLAST; PERIODONTAL DISEASE; REVIEW;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 33745885677     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20062267614     Document Type: Review

References (27)

1. Tanner A, Kent R, Maiden MF, Taubman MA. Clinical, microbiological and immunological profile of healthy, gingivitis and putative active periodontal subjects. J Periodontal Res 1996; 31: 195-204.
2. Schletter J, Heine H, Ulmer AJ, Rietschel ET. Molecular mechanisms of endotoxin activity. Arch Microbiol 1995; 164: 383-9.
3. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Anna Rev Immunol 1995; 13: 437-57.
4. Chaudhary PM, Ferguson C, Nguyen V, et al. Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood 1998; 91: 4020-7.
5. Chow JC, Xoung DW, Golenbock DT, et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J Biol Chem 1999; 274: 10689-92.
6. Nagasawa T, Kobayashi H, Kiji M, et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002; 130: 338-44.
7. Baker PJ, Dixon M, Evans RT, et al. CD4* T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999; 67: 2804-9.
8. Matsuki Y, Yamamoto T, Hara K. Interleukin-1 mRNA-expressing macrophages in human chronically inflamed gingival tissues. Am J Pathol 1991; 138: 1299-305.
9. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189-93.
10. Kikuchi T, Matsuguchi T, Tsuboi N, et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001; 166: 3574-9.
11. Kong YY, Boyle WJ, Penninger JM. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development, Immunol Cell Biol 1999; 77: 188-93.
12. Kawai T, Eisen-Lev R, Seki M, et al. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000; 164: 2102-9.
13. Josien R, Wang BR, Li HL, et al. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999; 162: 2562-8.
14. Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001; 12: 125-35.
15. Verhasselt V, Buelens C, Willems F, et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 1997; 158: 2919-25.
16. Bell. RANK Ligand and the regulation of skeletal remodeling. J Clin Invest 2003; 111: 1120-2
17. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-602.
18. Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 2000; 191: 275-86.
19. Hofbauer LC, Lacey DL, Dunstan CR, et al. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999; 25: 255-9.
20. Perkins SL, Kling SJ. Local concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation. Am J Physiol 1995; 269: E1024-30.
21. Zou W, Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 2002; 17: 1211-8.
22. Takami M, Woo JT, Nagai K. Requirement of osteoblastic cells for the fusion of osteoclasts. J Bone Miner Metab 1998; 16: 151-7.
23. Tani-Ishii N, Tsunoda A, Teranaka T, Umemoto T. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J Dent Res 1999; 78: 1617-23.
24. Jimi E, Akiyama S, Tsurukai T, et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999; 163: 434-42.
25. Itoh K, Udagawa N, Kobayashi K, et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 2003; 170: 3688-95.
26. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-76
27. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443-51.